Skadden Advises Endo In $168M Penwest Buy
The deal, announced Monday, values Penwest at $5 per share. The two companies have worked together since 1997 to develop and market Opana ER, a morphinelike drug used to treat moderate to severe pain in patients who need around-the-clock pain treatment for long periods of time.
The tender offer is expected to clear in September, and requires...
To view the full article, register now.